Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

We Wouldn't Be Too Quick To Buy Verizon Communications Inc. (NYSE:VZ) Before It Goes Ex-Dividend

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Verizon Communications Inc. (NYSE:VZ) is about to trade ex-dividend in the next four days. The ex-dividend date is one business day before a company's …

EODHD | 05 July 2024

Euronext Paris Growth Companies With High Insider Ownership In July 2024

Amid political uncertainties and fluctuating market indices, the French stock market has shown resilience, with the CAC 40 Index navigating through a challenging landscape as key elections loom. In such times, growth companies with high insider ownership can offer intriguing stability and commitment to …

EODHD | 05 July 2024

Here's Why Hold Strategy is Apt for PBF Energy (PBF) Now

PBF Energy PBF has witnessed upward earnings estimate revisions for 2024 and 2025 in the past 60 days. The stock, currently carrying a Zacks Rank #3 (Hold), has rallied 10.4% in the past six months compared with 6.4% growth of the composite stocks belonging …

EODHD | 05 July 2024

The Return Trends At UFP Industries (NASDAQ:UFPI) Look Promising

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. This shows us that …

EODHD | 05 July 2024

Here's Why Hold Strategy is Apt for Eni (E) Stock Right Now

Eni SpA E has witnessed upward earnings estimate revisions for 2024 and 2025 in the past 60 days. Factors Driving the Stock Favorable Style Score Eni has an impressive Value Score of B. Value Score helps find stocks that are undervalued. Back-tested results have …

EODHD | 05 July 2024

Does Universal Display (NASDAQ:OLED) Deserve A Spot On Your Watchlist?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. But the reality is that when a company loses money each year, for long enough, its investors will …

EODHD | 05 July 2024

AstraZeneca's (AZN) Tagrisso Gets EU Nod for First-Line NSCLC

AstraZeneca AZN announced that the European Commission (EC) has approved its blockbuster lung cancer drug, Tagrisso (osimertinib) for expanded use in a lung cancer indication. The EC has now approved Tagrisso in combination with chemotherapy for the first-line treatment of advanced EGFR-mutated (EGFRm) non-small …

EODHD | 05 July 2024

Teck Jumps on Buyback, Debt Plan After Coal Sale to Glencore

(Bloomberg) -- Shares of Teck Resources Ltd. jumped the most since April on the company’s plans to cut debt and return cash to shareholders thanks to proceeds from the sale of its steelmaking coal business to Glencore Plc. Most Read from Bloomberg Kamala Harris …

EODHD | 05 July 2024

Sapiens' (SPNS) Strong Portfolio, Clientele Make It a Buy Now

Sapiens International SPNS shares have returned 19.4% year to date, outperforming the Zacks Computer Software industry’s growth of 18.1% and the Zacks Computer and Technology sector’s return of 16.7%. SPNS has been benefiting from an innovative SaaS portfolio, which is helping it win new …

EODHD | 05 July 2024

Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD

This week, Eli Lilly LLY won a long-awaited FDA approval for its Alzheimer's disease (AD) drug, donanemab, to be sold under the brand name Kisunla. Sanofi SNY and partner Regeneron’s blockbuster drug Dupixent was approved for a new indication — chronic obstructive pulmonary disease …

EODHD | 05 July 2024
Support

Hi! How can we help you today?

Loading…